Cortezzo DonnaMaria E, Meyer Mark
Division of Neonatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Division of Pain and Palliative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Front Pediatr. 2020 Sep 11;8:574121. doi: 10.3389/fped.2020.574121. eCollection 2020.
Despite advances in technology and treatment options, over 15,000 neonates die each year in the United States. The majority of the deaths, with some estimates as high as 80%, are the result of a planned redirection of care or comfort measures only approach to care. When curative or life-prolonging interventions are not available or have been exhausted, parents focus on preserving quality of life and eliminating needless suffering. Parents hope their child will have a peaceful death and will not feel pain. A significant component of end-of-life care is high quality symptom evaluation and management. It is important that neonatal providers are knowledgeable in symptom management to address common sources of suffering and distress for babies and their families at the end-of-life (EOL). Medically complex neonates with life-threatening conditions are a unique patient population and there is little research on end-of-life symptom assessment and management. While there are tools available to assess symptoms for adolescents and adults, there is not a recognized set of tools for the neonatal population. Nonetheless, it is widely accepted that neonates experience significant symptoms at end-of-life. Most commonly acknowledged manifestations are pain, dyspnea, agitation, and secretions. In the absence of data and established guidelines, there is variability in their clinical management. This contributes to provider discomfort and inadequate symptom control. End-of-life symptom assessment and management is an important component of neonatal end-of-life care. While there remains a paucity of studies and data, it is prudent that providers adequately manage symptoms. Likewise, it is important that providers are educated so that they can effectively guide families through the dying process by discussing disease progression, physical changes, and providing empathetic support. In this review, the authors make recommendations for non-pharmacological and pharmacological management of end-of-life symptoms in neonates.
尽管技术和治疗方案不断进步,但美国每年仍有超过15000名新生儿死亡。大部分死亡病例(有些估计高达80%)是由于计划性地改变护理方向或仅采取舒适护理措施所致。当无法获得或已经用尽治愈性或延长生命的干预措施时,父母会专注于维持生活质量并消除不必要的痛苦。父母希望他们的孩子能平静地死去,不会感到疼痛。临终关怀的一个重要组成部分是高质量的症状评估和管理。新生儿护理人员了解症状管理知识非常重要,以便在临终时解决婴儿及其家庭常见的痛苦和困扰来源。患有危及生命疾病的复杂医疗状况新生儿是一个独特的患者群体,关于临终症状评估和管理的研究很少。虽然有评估青少年和成人症状的工具,但没有一套公认的针对新生儿群体的工具。尽管如此,人们普遍认为新生儿在临终时会出现明显症状。最常见的表现是疼痛、呼吸困难、烦躁和分泌物增多。在缺乏数据和既定指南的情况下,它们的临床管理存在差异。这导致护理人员感到不适,症状控制不足。临终症状评估和管理是新生儿临终关怀的重要组成部分。虽然研究和数据仍然匮乏,但护理人员妥善管理症状是谨慎之举。同样,对护理人员进行教育也很重要,这样他们就能通过讨论疾病进展、身体变化并提供同理心支持,有效地指导家庭度过死亡过程。在这篇综述中,作者对新生儿临终症状的非药物和药物管理提出了建议。